FDA proposes first phase of infant formula nutrient revisions

The U.S. Food and Drug Administration proposed revising four required nutrient standards for infant formula on October 29, beginning the first phase of a broader review of rules that have not been comprehensively updated since 1998. The proposal is not final, and the FDA says formulas currently on the market remain safe. The proposed changes cover iodine, manganese, vitamin A and vitamin D. They would adjust the permitted levels for each nutrient and establish a maximum manganese level for the first time. The proposal also changes how vitamins A and D are measured, permits a new source of vitamin A and revises labeling requirements. Existing requirements for chloride, potassium, selenium and sodium would remain unchanged. The FDA is seeking public comment on whether DHA, ARA and L-carnitine, which manufacturers commonly add but are not currently required, should become mandatory. Comments on the proposal are open through February 26, 2027. The agency plans to consider input as it continues its review. The proposal is the first of three planned phases examining the 30 nutrients required in infant formula and other potential requirements. The FDA plans to address additional...